SANTYL Trademark

Trademark Overview

On Friday, September 27, 1974, a trademark application was filed for SANTYL with the United States Patent and Trademark Office. The USPTO has given the SANTYL trademark a serial number of 73033211. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, October 18, 2025. This trademark is owned by KNOLL PHARMACEUTICAL COMPANY. The SANTYL trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATION DERIVED FROM CLOSTRIDIUM HISTOLYTICUM FOR ENZYMATIC DEBRIDEMENT
santyl

General Information

Serial Number73033211
Word MarkSANTYL
Filing DateFriday, September 27, 1974
Status800 - REGISTERED AND RENEWED
Status DateSaturday, October 18, 2025
Registration Number1017283
Registration DateTuesday, August 5, 1975
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATION DERIVED FROM CLOSTRIDIUM HISTOLYTICUM FOR ENZYMATIC DEBRIDEMENT

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code6 - Active
Class Status DateTuesday, March 1, 1983
Primary Code005
First Use Anywhere DateWednesday, January 31, 1973
First Use In Commerce DateWednesday, January 31, 1973

Trademark Owner History

Party NameSMITH & NEPHEW, INC.
Party Type33 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressMEMPHIS, TN 38116
Party NameHEALTHPOINT, LTD.
Party Type32 - New Owner After Registration
Legal Entity Type13 - Limited Partnership
AddressFORT WORTH, TX 76107
Party NameABBOTT LABORATORIES
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressABBOTT PARK, IL 60064
Party NameKNOLL PHARMACEUTICAL COMPANY
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMOUNT OLIVE, NJ 078281234

Trademark Events

Event DateEvent Description
Monday, November 3, 1980REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 4, 1995REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8
Thursday, September 14, 1995REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, July 26, 2005TEAS SECTION 8 & 9 RECEIVED
Tuesday, July 26, 2005REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Friday, October 28, 2005ASSIGNED TO PARALEGAL
Saturday, November 12, 2005REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, November 12, 2005REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, July 5, 2006AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, October 16, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 16, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 10, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 10, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 29, 2007CASE FILE IN TICRS
Wednesday, March 27, 2013AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, June 4, 2015TEAS SECTION 8 & 9 RECEIVED
Thursday, June 25, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 25, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, June 25, 2015REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Thursday, June 25, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, April 25, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 25, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 5, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, June 27, 2025TEAS SECTION 8 & 9 RECEIVED
Saturday, October 18, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, October 18, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, October 18, 2025REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
Saturday, October 18, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

santyl histolyticum enzymatic debridement clostridium from preparation derived pharmaceutical